Private Wealth Management Group, LLC Halozyme Therapeutics, Inc. Transaction History
Private Wealth Management Group, LLC
- $301 Billion
- Q2 2025
A detailed history of Private Wealth Management Group, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 73 shares of HALO stock, worth $4,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73
Previous 73
-0.0%
Holding current value
$4,679
Previous $4.66 Million
18.48%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
609Shares Held
126MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$785 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$380 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$222 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$218 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.93B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...